Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Disease sites
  • Colorectal
  • Stage distribution

Stage distribution

  • Charts and Tables

    Charts and Tables

    Figure 3.6

    Distribution of cases by stage at diagnosis for colorectal cancer – 2013 diagnosis year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    Includes BC, AB, SK, MB, NB, NS, PE, NL. ON is not included because ON excludes stage 0 from stage distribution reporting.
    Data from Stage II Not Otherwise Specified and Stage Not Applicable suppressed owing to small numbers.
    Data source: Provincial cancer agencies and programs.

    Data Table

    Stage at DiagnosisNumber of CasesPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    Stage 01,17912.011.412.7
    Stage I1,75117.817.118.6
    Stage II50.100.1
    Stage IIA1,70417.416.618.1
    Stage IIB2042.11.82.4
    Stage IIC1721.81.52
    Stage IIIA2812.92.53.2
    Stage IIIB1,54015.71516.4
    Stage IIIC5335.455.9
    Stage III Not Otherwise Specified390.40.30.5
    Stage IV240.20.10.3
    Stage IVA9039.28.69.8
    Stage IVB8558.78.29.3
    Stage IV Not Otherwise Specified140.10.10.2
    Stage Not Available210.20.10.3
    Stage Unknown5936.05.66.5

    + Expand Table

    Includes BC, AB, SK, MB, NB, NS, PE, NL. ON is not included because ON excludes stage 0 from stage distribution reporting.
    Data from Stage II Not Otherwise Specified and Stage Not Applicable suppressed owing to small numbers.
    Data source: Provincial cancer agencies and programs.

    Figure 3.10

    Distribution of cases by stage at diagnosis for ovarian cancer – 2013 diagnosis year

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    Includes BC, AB, SK, MB, NB, NS, PE, NL. ON is not included because ON excludes stage 0 from stage distribution reporting.
    Data for Stage IB, Stage I Not Otherwise Specified, Stage II, and Stage II Not Otherwise Specified suppressed owing to small numbers.
    Data source: Provincial cancer agencies and programs.

    Data Table

    Stage at DiagnosisNumber of CasesPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    Stage IA6212.19.314.9
    Stage IC6312.39.515.2
    Stage IIA102.00.83.2
    Stage IIB132.51.23.9
    Stage IIC142.71.34.1
    Stage IIIA244.72.96.5
    Stage IIIB142.71.34.1
    Stage IIIC15931.12735.1
    Stage III Not Otherwise Specified407.85.510.1
    Stage IV9518.615.221.9
    Stage Unknown193.72.15.3

    + Expand Table

    Includes BC, AB, SK, MB, NB, NS, PE, NL. ON is not included because ON excludes stage 0 from stage distribution reporting.
    Data for Stage IB, Stage I Not Otherwise Specified, Stage II, and Stage II Not Otherwise Specified suppressed owing to small numbers.
    Data source: Provincial cancer agencies and programs.

  • Data specifications

    Data specifications

    Definition: The percentage breakdown of incident cases by stage at diagnosis for breast, lung, colorectal, prostate and ovarian cancer

    Numerator: Number of stageable* incident cases in the provincial cancer registry for each stage at diagnosis (stage 0 – IV including occult, “Unknown”)

    Denominator: Total number of stageable incident cases (stage 0 through to “Not Available”)

    Exclusions:

    • Age (at diagnosis) 0 – 17
    • Non-melanoma skin cancer (M8050-8110 with site code C44.0 to C44.9)
    • Colorectal reporting for appendix C18.1
    • Lymphoma codes M-95 to M-98, all sarcoma codes

    Data source: Provincial cancer agencies

    Measurement timeframe: 2013 diagnosis year

    Stratification variable: Stage at diagnosis, disease site (breast, prostate, colorectal, lung (NSCLC, SCLC), ovarian)

    Provinces submitting data: BC, AB, SK, MB, NB, NS, PE, NL

    Province-specific notes:

    • AB: Hematology, sarcoma and melanoma morphologies were removed from the site-specific cancers. All 2012-2013 invasive primaries are collaboratively staged and once coded there should be no cases with missing/not available stage values. Currently “Not Available” indicates the number of cases that have a missing stage at the time of data pull as the registry status was not complete and staging information is still to come. Certain skin c44 with morphologies other than basal-squamous are also not staged according to Alberta Cancer Registry (ACR) rules. For this indicator, codes 8002, 8073 and 8803 are included as NSCLC.
    • SK: The denominator includes incident cases for which stage is recorded as “Not Applicable” since SK does not differentiate between “Not Applicable” and “Not Available” categories.
    • ON: Data submitted exclude stage 0 cases and thus are not presented in the stage distribution figure. ‘Breast’ only includes female breast cancer cases.
    • NB: From 2008 onwards, only the four most common cancers (breast, colorectal, lung and prostate cancers) are staged.

    Notes:

    1. The group stages for cancer incident cases were classified by AJCC Cancer Staging 7th edition.
    2. By AJCC, cancer incident cases are categorized in terms of stage as:
      1. Stageable: including stage 0, stage I through stage IV, stage unknown
      2. Not Applicable: Not stageable through AJCC
      3. Not Available: Cases for which stage data is not available or invalid
      4. Unknown: Cases for which there is insufficient information to ascertain a definitive stage
    3. Stage 0 includes in-situ and invasive cancer cases. Stage occult for lung cancer cases are included as well.
    4. Breast cancer cases only include females.
  • Related indicators

    Related Indicators

    Breast cancer screening

    Participation rate in breast cancer screening programs (%), by jurisdiction – 2014 screening year
    View this indicator
    Colorectal cancer screening

    Participation rate in colorectal cancer screening programs in a 30-month period (%), by jurisdiction – 2013-14 screening years combined
    View this indicator
    Capture of stage

    Percentage of incident cases for which stage data were available in provincial registries, by province, top 4 cancers and all cancers — 2012 and 2013 diagnosis years
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation